Children are not the only ones at high risk of developing the chronic neurological disorder narcolepsy in conjunction with the pandemic swine flu vaccine Pandemrix, according to a new study. The latest among several in recent years to link the two, the new paper found that people age 20 and younger have a roughly tripled risk of developing narcolepsy if they get the H1N1 jab, while people 30 and younger have about a doubled risk.
Affirming what Sweden and at least a dozen other countries discovered several years ago, the study determined that for every 100,000 people vaccinated with Pandemrix, which is manufactured by GlaxoSmithKline, an extra four cases of narcolepsy develop among those 20 and younger. For those between 21-30, an extra two cases per 100,000 were observed, according to Sweden’s Medical Products Agency. (more…)
Mon. Apr.1, 2013 by Blanche Levine
(NaturalHealth365) Low vitamin D levels can be the most damaging influence on our genetic health, according to professor George Ebers, Action Medical Research professor of Clinical Neurology and one of the senior authors of published scientific research.
What are the capabilities of vitamin D?
Researchers, at the University of Oxford, have shown the extent in which vitamin D interacts with our DNA. The researchers found 2,776 binding sites from the vitamin D receptor along the length of the genome. These are the ones unusually concentrated near a number of genes associated with autoimmune conditions such as MS, Crohn’s disease, systemic lupus, rheumatoid arthritis and cancers such as, lymphocytic leukemia and colorectal cancer. (more…)
A new “miracle” drug for the treatment of multiple sclerosis turns out to have been stolen (“derived”) from cordyceps mushrooms. The drug is called Gilenya and it’s being sold in the USA by Novartis AG — at the monopolistic price of $4,000 / month per person.
The drug is projected to be a blockbuster seller, with estimates putting it in the top 10 drugs by 2018 when it is expected to reach $5.3 billion in sales. A one-year course of Gilenya costs $48,000. (more…)
Multiple sclerosis (MS) is a neurological disorder affecting anywhere from 250,000 to 450,000 people in the US.1 MS is a chronic inflammatory disease of the central nervous system (CNS) with underlying immune abnormalities.2 The disease is more common in women than men and peaks at age 20 to 40. Multiple sclerosis presents differently in different patients with the symptoms ranging from mild neurological impairments to debilitating deficits of motor, cognitive, and visual function. Multiple sclerosis pathogenesis is believed to involve an autoimmune response within the CNS, resulting in demyelination and axonal injury. Inflammation and demyelination seem to be the primary pathology in the relapsing forms of MS, whereas neurodegeneration seems to dominate in the progressive forms of the disease.3 There is no definitive cause or cure for MS, and multiple etiologies are discussed in the literature. (more…)
MMF is a nasty neurological disorder with ties to multiple sclerosis and fibromyalgia. As we’ve come to expect, though, the WHO acts as if it’s more interested in covering up the cause – vaccines.
Photo by The JCB
by Heidi Stevenson
Originally posted November 2009
A new neurological disease, which is almost certainly caused by aluminum adjuvants in vaccines, is characterized by severe muscle and joint pain, inflammation with fever, and debilitating fatigue. Macrophagic myofasciitis (MMF), which is similar to, but diagnostically distinct from, fibromyalgia was first identified in 1993. Because adjuvant aluminum is the probable cause of MMF, some researchers have suggested that it may also be the cause of fibromyalgia.